GAF Vinyl Asbestos Floor Tile (1959–September 1981)

Manufacturer: GAF Corporation Years Produced: 1959–September 1981 Trust Fund: GAF Corporation Asbestos Settlement Trust

Product Description

GAF Corporation was one of the largest manufacturers of resilient flooring products in the United States throughout the mid-twentieth century. Among its most widely distributed product lines were vinyl asbestos floor tiles, sold under the GAF brand and installed in residential, commercial, and industrial settings across the country. These tiles were a standard specification material from the late 1950s through the late 1970s, prized for their durability, low cost, and ease of installation.

GAF vinyl asbestos floor tiles were typically manufactured in nine-inch and twelve-inch square formats and came in a broad range of colors and patterns intended to mimic stone, terrazzo, or decorative geometric designs. The tiles were produced by blending asbestos fibers with polyvinyl chloride (PVC) resin, plasticizers, and pigments under heat and pressure to form a dense, semi-flexible composite sheet that was then cut to size. This manufacturing process bound asbestos fibers throughout the body of each tile.

GAF sold these tiles through building supply distributors, flooring contractors, and hardware retailers. They were installed in factories, schools, hospitals, government buildings, apartment complexes, private homes, and virtually every category of commercial construction active during the production period. Because the tiles were inexpensive and easy to maintain, they were specified by architects and contractors as a default flooring solution for decades.

Production of GAF vinyl asbestos floor tiles continued until September 1981, when the product line was discontinued. By that time, regulatory pressure from the Environmental Protection Agency (EPA) and the Occupational Safety and Health Administration (OSHA), combined with mounting litigation over asbestos-related disease, had made continued manufacture untenable.

Asbestos Content

GAF vinyl asbestos floor tiles contained chrysotile asbestos as a primary reinforcing and binding component. Chrysotile, a serpentine-form asbestos, was used extensively in resilient flooring because its flexible fiber structure integrated readily into the vinyl matrix and improved the tile’s structural performance.

AHERA (Asbestos Hazard Emergency Response Act) regulations classify vinyl asbestos floor tile as a category of asbestos-containing material (ACM) subject to inspection, management, and abatement requirements in schools and public buildings. Under AHERA and subsequent EPA guidance, intact vinyl asbestos floor tiles are characterized as non-friable ACM, meaning the fibers are bound within the tile matrix under normal conditions. However, the tiles become a fiber-release hazard when cut, sanded, drilled, broken, or subjected to mechanical abatement — all of which were routine activities in installation and renovation work.

Asbestos content in vinyl floor tiles of this era typically ranged between approximately 15 and 35 percent by weight, though the precise formulation varied by product line and production period. The adhesives used to install these tiles — cutback adhesives and other mastics common through the 1970s — also frequently contained asbestos, compounding exposure for workers involved in installation and removal.

How Workers Were Exposed

Workers in a range of trades and industries encountered GAF vinyl asbestos floor tiles throughout their production, installation, and eventual removal. Industrial workers generally represent a significant portion of those exposed, given the widespread use of these tiles in manufacturing plants, warehouses, and processing facilities.

Flooring installers and tile layers faced direct exposure during the cutting and fitting of tiles. Scoring and snapping tiles by hand, or cutting them with hand saws, power saws, or scoring tools, released asbestos fibers into the breathing zone of workers without respiratory protection. Heating tiles to improve flexibility during fitting — a standard practice — could also release fibers.

Maintenance and custodial workers in facilities where GAF vinyl asbestos floor tiles had been installed were exposed when buffing, stripping, or sanding worn tile surfaces. Electric floor buffers and stripping machines abraded tile surfaces repeatedly over years of maintenance, generating airborne asbestos dust in enclosed spaces.

Renovation and demolition workers encountered some of the highest exposure levels when removing existing GAF tile installations. Chipping up bonded tiles with hand chisels, floor scrapers, or mechanical grinders released dense concentrations of asbestos fibers. When removal was performed in enclosed rooms with limited ventilation — conditions common in commercial renovation — workers could be exposed to fiber levels far exceeding the OSHA permissible exposure limit.

Industrial workers generally who worked in facilities floored with GAF vinyl asbestos tile were exposed through the ordinary mechanical wear and traffic damage that occurred over years of heavy use. Forklifts, pallet jacks, and heavy foot traffic on damaged or deteriorating tiles generated fiber release into the general plant environment.

Across all these exposure scenarios, a consistent factor was inadequate or absent respiratory protection. Prior to OSHA’s asbestos standards being strengthened in the 1970s and 1980s, most workers in these trades received no warning about the health hazards associated with asbestos-containing flooring products.

GAF Corporation filed for bankruptcy protection as a result of overwhelming asbestos liability arising from its manufacturing operations. As part of the bankruptcy resolution, the GAF Corporation Asbestos Settlement Trust was established to compensate individuals harmed by exposure to GAF asbestos-containing products, including vinyl asbestos floor tile.

Trust Fund: GAF Corporation Asbestos Settlement Trust

Individuals who were diagnosed with an asbestos-related disease after documented exposure to GAF vinyl asbestos floor tile may be eligible to file a claim with the GAF Corporation Asbestos Settlement Trust. The trust evaluates claims based on established eligibility criteria, including medical documentation of a qualifying disease and evidence of occupational or other exposure to a GAF asbestos-containing product.

Qualifying disease categories recognized in asbestos trust fund claims typically include:

  • Mesothelioma — malignant cancer of the pleural or peritoneal lining
  • Lung cancer — with documented asbestos exposure history
  • Asbestosis — progressive fibrotic lung disease caused by asbestos inhalation
  • Other asbestos-related conditions — including pleural plaques and pleural thickening, subject to trust-specific criteria

Filing eligibility generally requires that claimants demonstrate exposure to a GAF product during the manufacturing period (in this case, 1959 through September 1981), provide medical records establishing diagnosis, and supply work history documentation linking the claimant to job sites or occupations where GAF vinyl asbestos floor tile was present.

Because asbestos-related diseases carry strict statutes of limitations that vary by state, individuals who believe they were exposed to GAF vinyl asbestos floor tile and have received a relevant diagnosis are advised to consult with a qualified asbestos attorney as promptly as possible. An attorney experienced in asbestos trust fund claims can evaluate eligibility, gather necessary documentation, and file claims against the GAF Corporation Asbestos Settlement Trust and any other applicable trusts or defendants.

This article is provided for informational purposes based on documented regulatory, litigation, and trust fund records. It does not constitute legal advice. Individuals seeking compensation should consult a licensed attorney.